Journal Articles
Current Pharmaceutical Design
Year : 2014
Christelle Cheval : Connect in order to contact the contributor
https://univ-lyon1.hal.science/hal-02046812
Submitted on : Friday, February 22, 2019-7:05:02 PM
Last modification on : Sunday, May 19, 2024-3:09:55 AM
Dates and versions
Identifiers
- HAL Id : hal-02046812 , version 1
Cite
Sylvain Goutelle, Laurent Bourguignon, P. Maire, R. W. Jelliffe, M. Neely. The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy. Current Pharmaceutical Design, 2014, 20, pp.6191-6206. ⟨hal-02046812⟩
Collections
17
View
0
Download